Latest news
AIM Stock Soars 42% As Pancreatic Cancer Trial Hits Key Enrollment Milestone Before Schedule — CEO Sees 'Significant Value-Inflection Period' Ahead - StocktwitsStocktwits · Sat, 08 Aug 2026 04:12:05 GMTDRTS Stock Gets A Pre-Market Boost – Retail Shrug Off Wider Q1 Loss Ahead Of Key Pancreatic Cancer Data Reveal This Week - StocktwitsStocktwits · Fri, 07 Aug 2026 03:40:14 GMTRenovoRx to Highlight TAMP™ Platform at JonesTrading Virtual Key Opinion Leader Webinar on the Evolving Pancreatic Cancer Landscape, August 13th - The Manila TimesThe Manila Times · Tue, 04 Aug 2026 12:40:56 GMTRenovoRx Webinar to Explore Local Chemotherapy for Pancreatic Cancer - Stock TitanStock Titan · Tue, 04 Aug 2026 12:30:00 GMT